Pharmaceuticals Wholesaling in the US - Industry Market Research Report

Double dose: Demand for medications for chronic conditions among the elderly will likely remain robust

The Pharmaceuticals Wholesaling industry has grown as changing demographics, along with a rising number of physician visits, have propelled demand. The aging of the US population has also boosted revenue growth, as individuals generally require and purchase more medications as they get older. As a result, revenue is expected to increase at a CAGR of 5.3% to $1.3 trillion over the five years to 2023. However, intense external competition from e-commerce pharmaceutical retailers has pressured the industry, which is expected to fuel increased consolidation as wholesalers attempt to bolster profit margins by establishing economies of scale.

This industry distributes medicines intended to diagnose, treat and prevent diseases. The industry includes operators that take ownership of goods to be distributed, and does not include manufacturers that sell medicines, equipment and supplies directly to hospitals or doctors’ offices.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.